Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection

Canadian Journal of Gastroenterology

Volumn 19, Issue 10, 2005, Pages 625-629

  Gan, S I ^a   Devlin, S M ^a   Scott Douglas, N W ^a   Burak, Kelly W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antiviral therapy; Hepatitis B; Nephrotic syndrome

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; NONSTEROID ANTIINFLAMMATORY AGENT; PRAVASTATIN;

ADULT; CASE REPORT; CHINESE; CHRONIC HEPATITIS; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLU LIKE SYNDROME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; MEDICAL LITERATURE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; VIROLOGY; VIRUS REACTIVATION;

EID: 28444455164     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/378587     Document Type: Review

References (45)

1. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV associated nephrotic syndrome: Resolution with oral lamivudine. Arch Dis Child 2003;88:446-9.
2. Filler G, Feber J, Weiler O, Le Saux N. Another case of HBV associated membranous glomerulonephritis resolving on lamivudine. Arch Dis Child 2003;88:460.
3. Balal M, Seyrek N, Karayayali I, Paydas S, Gonlusen G. Use of immunosuppressive drugs and lamivudine in a patient with nephrotic syndrome, severe renal failure, and HBV cirrhosis: Case report. Adv Ther 2003; 20:191-4.
4. Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971;2:234-7.
5. Hirschel BJ, Benusiglio LN, Favre H, et al. Glomerulonephritis associated with hepatitis B. Report of a case and review of the literature. Clin Nephrol 1977:404-9.
6. Iida H, Izumino K, Asaka M, et al. Membranoproliferative glomerulonephritis associated with chronic hepatitis B in adults: Pathogenetic role of HBsAg. Am J Nephrol 1987;7:319-24.
7. Myers BD, Griffel B, Naveh D, Jankielowiiz T, Klajman A. Membrano-proliferative glomerulonephritis associated with persistent viral hepatitis. Am J Clin Pathol 1973;60:222-8.
8. Stratta P, Camussi G, Ragni R, Vercellone A. Hepatitis-B antigenaemia associated with active chronic hepatitis and mesangioproliferative glomerulonephritis. Lancet 1975;2:179.
9. Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol 2004;24:198-211.
10. Michalak T. Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases. Am J Pathol 1978;90:619-32.
11. Lai K, Lai F, Lo S, Ho C, Chan K. IgA nephropathy associated with hepatitis B virus antigenemia. Nephron 1987;47:141-3.
12. Lai K, Lai F, Tam J, Vallance-Owen J. Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol 1988;29:229-34.
13. Lai K, Lai F, Tam J. IgA nephropathy associated with chronic hepatitis B virus infection in adults: The pathogenetic role of HBsAg. J Pathol 1989;157:321-7.
14. Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V. Membranous glomerulonephritis and hepatitis B surface antigen in children. J Pediatr 1979;95:946-52.
15. Yoshikawa N, Ito H, Yamada Y, et al. Membranous glomerulonephritis associated with hepatitis B antigen in children: A comparison with idiopathic membranous glomerulonephritis. Clin Nephrol 1985;23:28-34.
16. Lai K, Li P, Lui S, et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991;324:1457-63.
17. Hsu H, Lin G, Chang M, Chen C. Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol 1983;20:121-9.
18. Wiggelinkhuizen J, Sinclair-Smith C, Stannard L, Smuts H. Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child 1983;58:488-96.
19. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990;37:663-76.
20. Wong SN, Yu EC, Chan KW. Hepatitis B virus associated membranous glomerulonephritis in children-experience in Hong Kong. Clin Nephrol 1993;40:142-7.
21. Brzosko WJ, Krawczynski K, Nazarewicz T, Morzycka M, Nowoslawski A. Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 1974;2:477-82.
22. Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V. HBsAg glomerular deposits in glomerulonephritis: Fact or artifact? Kidney Int 1981;19:579-86.
23. Kohler PF, Cronin RE, Hammond WS, Olin D, Carr RI. Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med 1974;81:448-51.
24. Furuse A, Hattori S, Terashima T, Karashima S, Matsuda I. Circulating immune complex in glomerulopathy associated with hepatitis B virus infection. Nephron 1982;31:212-8.
25. Gregorek H, Jung A, Grabowska B, Madalinski K. Isolation and partial characterization of circulating immune complexes in sera of children with HBV-mediated glomerulonephritis. Arch Immunol Ther Exp (Warsz) 1991;39:519-27.
26. He X, Fang L, Zhang Y, Sheng F, Zhang X, Guo M. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr Nephrol 1998;12:117-20.
27. Lai KN, Ho RT, Tam JS, Lai FM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis. Kidney Int 1996;50:1965-77.
28. Lai K, Tam J, Lin H, Lai F. The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 1990;54:12-7.
29. Wyszynska T, Jung H, Madalinski K, Morzycka M. Hepatitis B mediated glomerulonephritis in children. Int J Pediatr Nephrol 1984;5:147-58.
30. Scullard G, Smith C, Merigan T, Robinson W, Gregory P. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981;81:987-91.
31. Quan A, Portale A, Foster S, Lavine J. Resolution of hepatitis B virus-related membranoproliferative glomerulonephritis after orthotopic liver transplantation. Pediatr Nephrol 1995;9:599-602.
32. Esteban R, Buti M, Valles M, Allende H, Guardia J. Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate. Hepatology 1986;6:762-3.
33. Lin C, Lo S. Treatment of hepatitis B virus-associated membranous nephropathy with adenine arabinoside and thymic extract. Kidney Int 1991;39:301-6.
34. Shapiro R, Steinbrecher U, Magil A. Remission of nephrotic syndrome of HBV-associated membranous glomerulopathy following treatment with interferon. Am J Nephrol 1995;15:343-7.
35. Garcia G, Scullard G, Smith C, et al. Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatology 1985;5:317-20.
36. Chung DR, Yang WS, Kim SB, et al. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 1997;17:112-7.
37. Conjeevaram H, Hoofnagle J, Austin H, Park Y, Fried M, Di Bisceglie A. Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 1995;109:540-6.
38. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995;47:225-30.
39. Wong SN, Yu EC, Lok AS, Chan KW, Lau YL. Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 1992;6:417-20.
40. Jonas M, Ragin L, Silva M. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: Treatment with recombinant interferon alfa. J Pediatr 1991;119:818-20.
41. Lisker-Melman M, Webb D, Di Bisceglie AM, et al. Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Ann Intern Med 1989;111:479-83.
42. Mizushima N, Kanai K, Matsuda H, et al. Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 1987;92:524-6.
43. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993;119:312-23.
44. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 2001;120:1828-53.
45. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997;349:1857-63.